Am I a Good Candidate for the O-Shot? Who It Helps and Who It Does Not

Short answer: the O-Shot is a precision tool, not a general-purpose fix. It helps most with four fairly specific concerns. For several other very common complaints, something else should come first - and a clinic that skips that conversation is selling you an injection rather than treating you. This page is a screening guide, so you can walk in already knowing roughly where you sit.

Not sure what the O-Shot even is yet? Read our full guide to the O-Shot in Ann Arbor, MI first - it covers the procedure step by step, the results timeline, how many sessions are typical, and current pricing. Come back here when your question has become "but is it right for me?"

The four concerns the O-Shot matches best

Platelet-rich plasma rebuilds tissue. That means it helps when your symptom is caused by tissue that has thinned, lost blood supply, or lost sensitivity - and it helps less when your symptom is caused by muscle, hormones, nerve pain from another source, or something psychological. The strongest matches:

• Reduced arousal, sensation, or difficulty reaching orgasm that started or worsened around perimenopause and did not fully resolve once hormones were addressed.
• Reduced sensitivity or numbness in a specific area, often after childbirth or after certain pelvic surgery.
• Vestibulodynia - a well-localised pain at the vaginal opening - that has not responded to first-line care.
• Mild-to-moderate stress urinary incontinence, the leaking that happens with a cough, sneeze, or workout, that is not severe enough to warrant surgery.

A pattern worth noticing: all four are problems of tissue quality in a defined place. If you can point to where the problem is, PRP has something to work with.

Who should treat something else first

This is the section most O-Shot pages leave out, and it is the one that saves people money.

Significant untreated genitourinary syndrome of menopause. If low estrogen has left the tissue thin, dry, and fragile, local hormone therapy is the first move. It changes the environment the PRP has to work in. Treating the tissue before you have treated the hormone that maintains that tissue is doing the steps out of order - and we would rather sequence it properly than have you pay for a result you were never set up to get. Our guide to the O-Shot after childbirth and after menopause goes through that sequencing.

Pelvic floor muscle dysfunction. If the muscles are overactive and holding tension, that produces pain with entry, and no injection will release a muscle. Pelvic floor physical therapy will. If the muscles are underactive, training them is the higher-yield first step. Notably, in stress incontinence the two work well together rather than one replacing the other - but the therapy still needs to happen.

Deep pelvic pain. Pain felt deep rather than at the opening, especially pain that tracks with your cycle, needs its own workup. Endometriosis, adenomyosis, ovarian pathology, and bowel conditions all present this way. Injecting the vestibule does not address any of them.

Low desire with no physical trigger. Desire is genuinely multifactorial - sleep, stress, medication side effects, relationship context, thyroid, iron, and mood all feed into it. If arousal and sensation are physically intact and it is desire itself that has gone, the O-Shot is aiming at the wrong target. Start with why low libido in women has many causes.

Severe stress incontinence or significant prolapse. These are structural, and surgical evaluation is the honest recommendation. Our detailed page on the O-Shot for bladder leaks covers where that line sits and what the randomized evidence supports.

Absolute reasons we would not treat you

These are not judgment calls. If any apply, the answer is no, or not yet:

• Active infection in or near the treatment area
• A bleeding or clotting disorder, or a platelet abnormality
• Active cancer
• Pregnancy
• Anything that makes it unsafe to draw blood or to pause antiplatelet medication safely

Some situations are neither a yes nor a no and simply need review: a history of hormone-sensitive cancer, ongoing anticoagulation, an autoimmune condition on immunosuppressive treatment, or previous pelvic surgery or radiation. Bring the records. We would rather spend the consultation reading your history than guessing.

What the evidence base honestly looks like

You deserve to know the quality of the research, not just its direction.

A systematic review of PRP in gynaecology pooled twelve studies covering 327 women with a mean age of 51. For sexual dysfunction, PRP significantly improved the Female Sexual Function Index, the Vaginal Health Index, and the Female Sexual Distress score. For stress incontinence, it significantly improved ICIQ-SF and UDI-6 scores. The same authors rated the overall level of evidence as low, because the studies were small and their protocols inconsistent, and they called for higher-quality trials (Dankova et al., Biomedicines, 2023; doi:10.3390/biomedicines11112919).

A more recent systematic review looked specifically at PRP given into the vulvovaginal area as a stand-alone outpatient procedure. Eighteen studies covering 480 patients, 401 of whom received PRP, showed improvements in symptoms, sexual function, and vaginal health, with adverse events that were few and mild. The commonest indications studied were vulvar lichen sclerosus, sexual dysfunction, and vulvovaginal atrophy. The authors again flagged wide variation in preparation and injection protocols between clinics (De Ponte et al., The Journal of Sexual Medicine, 2026; doi:10.1093/jsxmed/qdaf307).

What that means for you as a candidate: the direction of benefit is consistent and the safety profile is reassuringly good across hundreds of treated women. The size of benefit for any individual is less predictable, and it depends heavily on whether your problem is the kind PRP addresses. Which is the whole point of this page.

A five-question self-check before you book

1. Can you localise it? A specific area of reduced sensation, or leakage tied to pressure, points toward PRP. A diffuse sense that everything has faded points toward a hormone and whole-picture assessment first.
2. Have your hormones been properly looked at? Not a single TSH from three years ago. Estradiol, testosterone, DHEA-S, and thyroid, interpreted against your symptoms.
3. Has anyone examined the tissue? Distinguishing atrophy from muscle tension from a localised pain point requires an exam, not a form.
4. Have you tried the first-line thing for your actual problem? Local estrogen for atrophy, pelvic floor therapy for muscle issues, bladder retraining for urge leakage.
5. Is your expectation calibrated? Meaningful improvement in a defined problem over eight to twelve weeks is the realistic goal. A total reset of how sex felt at 28 is not, and anyone promising it is not being straight with you.

What screening at Arbour Longevity actually involves

Your first visit is a clinical assessment, not a sales appointment. We take a full history including births, surgery, medication, and when symptoms began. We look at hormone status and order labs where the picture is incomplete. We examine rather than assume. And we establish a baseline using validated instruments - the FSFI for sexual function, UDI-6 and ICIQ-SF where leakage is part of the story - so that any later claim of improvement can actually be checked.

At the end of it you get a straight answer, including "not this, do that first" when that is the honest one. Because Gandhi is triple board certified across family practice, psychiatric mental health, and anti-aging and functional medicine, the assessment covers the hormonal, physical, and psychological threads together rather than treating them as separate appointments in separate buildings.

Candidacy questions we are asked most

Is there an age limit?

No. The studies pooled in the reviews above had a mean participant age of around 51, with a wide spread either side. Candidacy is about tissue, health status, and what your actual problem is, not about a number.

Am I a candidate if I am postmenopausal?

Very often yes, and vulvovaginal atrophy was one of the three commonest indications in the 2026 review. The usual caveat applies: if there is significant untreated atrophy, local hormone therapy generally comes first so the tissue can respond.

What if I am on a blood thinner?

Do not stop it on your own. Bring the prescription and the reason for it. Depending on the medication and the indication, this may be a scheduling question rather than a refusal, and it may be a firm no. It is decided with the clinician who manages that medication, not unilaterally.

What if I am still having periods?

That is not a barrier. Many women in perimenopause are excellent candidates - it is one of the commonest reasons people come in. We may simply avoid scheduling the procedure during your heaviest days for comfort.

Do I have to commit to a series?

No. We agree on a plan, reassess with the same measurements we took at baseline, and decide about further sessions from that. Sessions you do not need are not recommended.

What if you tell me I am not a candidate?

Then you leave with a plan for the thing that will actually help, and the $35 you spent bought you a real answer instead of a treatment aimed at the wrong problem.

The next step

If you recognised yourself in the first list, book. If you recognised yourself in the second, book anyway and say so - the sequencing conversation is the valuable part. If your interest is really about you and a partner both noticing changes, our page on planning the O-Shot and P-Shot together as a couple is the better starting point.

Consultations are private, the conversation is direct and free of judgment, and your notes are confidential.

Your first visit is $35, applied toward treatment if you proceed. Call or text (734) 436-3357. Arbour Longevity, 2217 Packard St, Suite 15, Ann Arbor, MI 48104. Open Thursday through Monday, 10:00 to 19:00; closed Tuesday and Wednesday. Parking is free and directly outside, with no meters and no parking structure. Suite 15 is down a flight of stairs - call ahead on (734) 436-3357 if stairs are difficult for you.

Book your $35 consultation

References

1. Dankova I, Pyrgidis N, Tishukov M, et al. Efficacy and Safety of Platelet-Rich Plasma Injections for the Treatment of Female Sexual Dysfunction and Stress Urinary Incontinence: A Systematic Review. Biomedicines. 2023;11(11):2919. PMID 38001920. doi:10.3390/biomedicines11112919
2. De Ponte A, Cabrera S, Bermúdez Sparice SS, Baulies S, Rodríguez I. Platelet-rich plasma in the management of vulvovaginal disorders: a systematic review. The Journal of Sexual Medicine. 2026;23(1). PMID 41168677. doi:10.1093/jsxmed/qdaf307
3. Saraluck A, Chinthakanan O, Kijmanawat A, et al. Autologous platelet rich plasma combined with pelvic floor muscle training for female stress urinary incontinence: a randomized control clinical trial. Neurourology and Urodynamics. 2024;43(2):342-353. PMID 38108468. doi:10.1002/nau.25365
4. American College of Obstetricians and Gynecologists. Your Sexual Health. acog.org

This content is educational and does not constitute medical advice. Candidacy for the O-Shot is determined by clinical evaluation. Individual results vary.